Your browser doesn't support javascript.
loading
A comparison of COVID-19 incidence rates across six European countries in 2021.
Padget, Michael; Adam, Pauline; Dorfmuller, Marina; Blondel, Clara; Campos-Matos, Ines; Fayad, Myriam; Mateo-Urdiales, Alberto; Mesher, David; Pistol, Adriana; Rebolledo, Javiera; Riccardo, Flavia; Riess, Maximilian; Rusu, Lavinia Cipriana; Che, Didier; Coignard, Bruno.
Affiliation
  • Padget M; Santé Publique France, Saint Maurice, France.
  • Adam P; Santé Publique France, Saint Maurice, France.
  • Dorfmuller M; Santé Publique France, Saint Maurice, France.
  • Blondel C; Santé Publique France, Saint Maurice, France.
  • Campos-Matos I; COVID Vaccines and Epidemiology, UK Health Security Agency, United Kingdom.
  • Fayad M; Santé Publique France, Saint Maurice, France.
  • Mateo-Urdiales A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Mesher D; International COVID Team, UK Health Security Agency, United Kingdom.
  • Pistol A; National Institute of Public Health Bucharest, Romania.
  • Rebolledo J; University of Medicine "Carol Davila" Bucharest, Romania.
  • Riccardo F; Department of epidemiology and infectious diseases, Sciensano, Brussels, Belgium.
  • Riess M; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Rusu LC; Public Health Agency of Sweden, Stockholm, Sweden.
  • Che D; National Institute of Public Health Bucharest, Romania.
  • Coignard B; Santé Publique France, Saint Maurice, France.
Euro Surveill ; 28(40)2023 10.
Article in En | MEDLINE | ID: mdl-37796443
ABSTRACT
International comparisons of COVID-19 incidence rates have helped gain insights into the characteristics of the disease, benchmark disease impact, shape public health measures and inform potential travel restrictions and border control measures. However, these comparisons may be biased by differences in COVID-19 surveillance systems and approaches to reporting in each country. To better understand these differences and their impact on incidence comparisons, we collected data on surveillance systems from six European countries Belgium, England, France, Italy, Romania and Sweden. Data collected included target testing populations, access to testing, case definitions, data entry and management and statistical approaches to incidence calculation. Average testing, incidence and contextual data were also collected. Data represented the surveillance systems as they were in mid-May 2021. Overall, important differences between surveillance systems were detected. Results showed wide variations in testing rates, access to free testing and the types of tests recorded in national databases, which may substantially limit incidence comparability. By systematically including testing information when comparing incidence rates, these comparisons may be greatly improved. New indicators incorporating testing or existing indicators such as death or hospitalisation will be important to improving international comparisons.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Incidence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Euro Surveill Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Incidence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Euro Surveill Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: